July 25, 2007 – According to a study published in the July 25 issue of JAMA, high-risk patients with hypertrophic cardiomyopathy (HCM) may reduce the risk of sudden cardiac death with an implantable cardioverter-defibrillator that terminates dangerous heart rhythm disorders.
The studies indicates that clinicians have been using implantable cardioverter-defibrillator (ICD) as a potentially life-saving treatment in high-risk patients with HCM, however, the effectiveness and appropriate selection of HCM patients for this therapy remains uncertain.